(R)-1-Boc-Piperazine-2-carboxylic acid

Catalog No.: 
ACYEVZ903
CAS No.: 
278788-60-6
Molecular Formula: 
C10H18N2O4
Molecular Weight: 
230.26
(R)-1-Boc-Piperazine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$73.00In stockIn stock
25g97%$246.00In stockIn stock
100g97%$954.00In stockInquiry
500g97%$4627.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-1-Boc-Piperazine-2-carboxylic acid
IUPAC Name(R)-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid
MDL No.MFCD02179106
Molecular FormulaC10H18N2O4
Molecular Weight230.26
SMILESO=C([C@@H]1N(C(OC(C)(C)C)=O)CCNC1)O
InChI KeyMPOFEHGMWPHBSF-SSDOTTSWSA-N
Synonym(R)-1-N-Boc-Piperazine-2-carboxylic acid | (R)-4-Boc-Piperazine-3-carboxylic acid | (R)-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid
CAS No.278788-60-6
PubChem CID24820285

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACYEVZ903 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUXZY057 route compound structure diagram
    ACUXZY057138775-02-7In Stock
  2. Then
  3. ACYEVZ903 route product structure diagram
    ACYEVZ903278788-60-6In Stock
Inquiry

2. ACYEVZ903 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRMXG896 route compound structure diagram
    ACRMXG896126330-90-3In Stock
  4. Then
  5. ACYEVZ903 route product structure diagram
    ACYEVZ903278788-60-6In Stock
Inquiry

3. ACYEVZ903 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYEVZ903 route product structure diagram
    ACYEVZ903278788-60-6In Stock
Inquiry

Comments (0)